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Abstract 1 
Background: Although persistent drainage and hematoma formation are recognized risk 2 
factors for development of periprosthetic infection, it is not known that excess 3 
anticoagulation is a predisposing factor.  4 
Methods: We conducted a 2 to 1 case-control study with 78 cases that underwent 5 
revision for septic failure. The controls underwent the same index procedure but did not 6 
develop consequent infection. Patient co-morbidities, medications, intraoperative, and 7 
postoperative factors were compared. 8 
Results: Postoperative wound complications including development of hematoma and 9 
wound drainage were significant risk factors for periprosthetic infection. A mean INR 10 
>1.5 was found to be more prevalent in patients who developed of postoperative wound 11 
complications and subsequent periprosthetic infection.  12 
Conclusions: Cautious anticoagulation to prevent hematoma formation and/or wound 13 
drainage is critical to prevent periprosthetic infection and its undesirable consequences. 14 
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 20 
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 22 
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Introduction 1 
Despite immense improvements in prevention and treatment, the management of 2 
periprosthetic infection continues to be challenging1-4. The incidence of periprosthetic 3 
infection after primary arthroplasty is less than 1%5 and up to 7%6,7 after revision joint 4 
arthroplasty. Numerous risk factors for periprosthetic infection have been identified8,9. 5 
Immunocompromised status of the patient, skin lesions such as psoriatic plaques, and 6 
problems related to wound healing are some of the predisposing factors for periprosthetic 7 
infection following total joint arthroplasty10-13. 8 
In a previous case-controlled study, patients with delayed wound discharge, 9 
wound dehiscence and hematoma formation were found to have a higher incidence of 10 
periprosthetic infection8. Although the latter finding appears intuitive, the exact etiology 11 
of wound problems following joint arthroplasty was not elucidated in the stated study8. 12 
We hypothesized that patients receiving ‘excessive’ anticoagulation, defined as 13 
International Randomized Ration (INR) greater than clinically intended level, may be at 14 
risk of developing wound related problems which in turn predisposed them to 15 
periprosthetic infection. This case-control study was conceived to examine the correlation 16 
between anticoagulation and periprosthetic infection. 17 
 18 
Materials and Methods 19 
Study Group 20 
Institutional review board approval was obtained prior to initiation of this case-21 
control study. The cohort consisted of all patients who underwent primary or revision 22 
total knee or total hip arthroplasty for an aseptic diagnosis during the period of 2000 to 23 
 4 
2005 and developed subsequent periprosthetic infection. The diagnosis of periprosthetic 1 
infection was reached on the basis of patients having at least three out of five of the 2 
following criteria: 1) abnormal serology (ESR >30 mm/hr; CRP >1mg/dl), 2) strong 3 
clinical and radiographic suspicion for periprosthetic infection, 3) positive joint aspiration 4 
culture, 4) evidence of purulence during the subsequent surgical intervention, and 5) 5 
positive intraoperative culture14.  The patients with periprosthetic infection were then 6 
closely matched in a 2:1 ratio with those undergoing the same procedure who did not 7 
develop periprosthetic infection following their index surgery. The matching criteria 8 
included the underlying diagnosis, the type of prosthesis, mode of fixation, surgeon, 9 
height, weight, age, gender, and the year of surgery.  10 
A thorough review of the medical records was performed to extract the relevant 11 
information, which included socio-demographic factors such as age, gender, body mass 12 
index, alcohol abuse and smoking habits. Information was also gathered regarding the 13 
medication history with special emphasis on steroid therapy and insulin requirement. 14 
Detailed information about the patient’s medical history including inflammatory 15 
arthropathy, autoimmune disease, diabetes mellitus, malignancy, and any other 16 
concomitant medical conditions were gathered. A history of septic arthritis of the native 17 
joint or any other infection was considered relevant to our analysis. The postoperative 18 
course, and in particular the details of anticoagulation and the level of INR, for all these 19 
patients following their index primary arthroplasty was recorded. Detailed data regarding 20 
the intraoperative and postoperative course of these patients related to their index surgery 21 
was also collected which also included the National Nosocomial Infections Surveillance 22 
(NNIS) surgical index score15. The NNIS collates information on the comorbidities, 23 
 5 
operative time, and the surgical wound classification and has been shown to be an 1 
important confounder for periprosthetic infection8. We documented the type, time of 2 
administration, and duration of prophylactic antibiotic that was given to the patients 3 
during the index arthroplasty. All intraoperative and postoperative transfusions of 4 
autologous or allogenic nature were also recorded.    5 
Socio-demographics 6 
The infected group included 42 males (54%) and 36 females (46%). Fifty-six 7 
percent of the cases and 51% of the controls were considered obese at the time of index 8 
surgery (BMI >30 Kg/m2). There was no significant difference in the mean BMI, 9 
smoking habit, and alcohol abuse between the cases and the controls (Table1).  10 
Postoperative Protocols 11 
All patients at our institution undergoing joint arthroplasty are placed on low dose 12 
warfarin (goal INR= 1.5) unless indicated otherwise. Warfarin is administered on the day 13 
of surgery and continued for a period of six weeks. Deviations from the latter occurred if: 14 
a) the patient was on anticoagulation prior to the surgery for conditions such as 15 
arrhythmia or replaced heart valve, b) had known allergy to warfarin, or c) developed 16 
thromboembolism in the postoperative period. In the latter three categories of patients 17 
subcutaneous and/or intravenous heparin was used as the sole or the bridging agent until 18 
adequate and full anticoagulation (goal INR=2-3) with the oral agent could be 19 
established. 20 
Prophylaxis for infection using cephalosporin antibiotics (Ancef, 1 gram) or an 21 
alternative antibiotic for patients with penicillin allergy is also administered within 60 22 
minutes of arthroplasty procedure and continued for 24 hours postoperatively. Antibiotic 23 
 6 
was administered at a mean of 39 minutes (range, 0-60 minutes) prior to incision among 1 
the cases and controls respectively. Cephalosporin was the most frequently administered 2 
antibiotic in both groups [cases (72%); controls (88%)] followed by vancomycin [cases 3 
(18%); controls (8%)].  4 
The wound management consisted of application of a sterile dressing that was 5 
placed over the wound in the operating room and usually kept for 24 hours. The wound 6 
was then inspected and covered by dry gauze that was changed at least twice daily during 7 
the hospital stay. The wound was monitored by the patient and/or the visiting nurses after 8 
discharge from hospital. Fluid discharge from the wound beyond postoperative day 7 was 9 
deemed clinically significant and abnormal.  10 
Surgical Data 11 
Degenerative joint arthritis was the most common diagnosis in both groups. Other 12 
diagnoses included post-traumatic arthritis (4 cases), and inflammatory arthropathy (two 13 
cases). Among the 78 patients in the infected group, 43 had undergone total knee 14 
arthroplasty (33 primary and 10 revisions), and 35 patients received total hip arthroplasty 15 
(12 primary and 23 revisions). The mean duration between index joint arthroplasty and 16 
the development of infection was 256 days (range, 4-1890 days). Gram-positive cocci 17 
were the most common infecting organisms including Staphylococcus coagulase negative 18 
(26%), Staphylococcus aureus (16%), Methicillin resistant Staphylococcus aureus 19 
[MRSA] (14%), and other Streptococcus species (13%).  20 
Statistical Analysis 21 
We performed descriptive statistics using SAS version 9.1 to determine the 22 
means, standard deviations, and the frequency distribution of the various variables 23 
 7 
described above. The NNIS index score was stratified into two categories including 0 and 1 
greater than or equal to one. Unadjusted analysis was performed using Wilcoxon 2 
procedure to compare the means across the continuous variables among the cases and 3 
controls. Fisher exact test was used to compare the proportions across the categorical 4 
variables in the cases and controls. We analyzed continuous variables using t-statistics, 5 
while Chi-Square analysis was used for categorical variables. A p-value of <0.05 6 
depicted statistical significance. Adjusted analysis was performed using multivariate 7 
stepwise logistic regression to determine the variables predicting infection in this study 8 
population. 9 
Results: 10 
Postoperative Course       11 
Patients who subsequently developed infection had a more protracted 12 
hospitalization course with two times the number of postoperative complications 13 
(p=0.02) following their index arthroplasty compared to the control patients (Table 1). 14 
The mean hospital length of stay in the 78 patients with subsequent periprosthetic 15 
infection was significantly longer at 6 days (range, 1-11 days) compared to 4 days (range, 16 
2-6 days) in the group of 156 patients without infection (p<0.006). Infected patients were 17 
12.6 times more likely to develop hematoma compared to their respective controls and 18 
16.8 times more likely to have persistent wound drainage. Although the cases had only 19 
slightly higher intraoperative blood loss, they had significantly higher postoperative 20 
transfusions compared to control patients (Table1). Wound dehiscence developed 21 
following the index arthroplasty in two patients both of whom later developed infection.  22 
 8 
 There was a significantly higher number of reoperations following the index 1 
surgery in the group of patients who later became infected (total of 14 reoperations) 2 
compared to the control patients (total of 3 reoperations) (OR=11.2, p<0.0001). The 3 
indication for reoperation included evacuation of hematoma (9 patients), debridement and 4 
wash out of draining wound (3 patients), and debridement and closure for wound 5 
dehiscence (2 patients) in the infection group. Among the controls, only two patients 6 
underwent evacuation of hematoma, while one was reoperated for delayed wound 7 
healing.   8 
Stratified Analysis For Anticoagulation 9 
Although the mean INR at all time points was higher in the cohort of patients who 10 
developed periprosthetic infection compared to those who did not develop infection, this 11 
difference was not found to be statistically different (p=0.06). However, the INR level 12 
was statistically higher in patients with wound related problems who later developed 13 
infection compared to patients who did not develop infection (p=0.03). In addition, a 14 
significantly greater percentage of infected patients (17%) had an INR level >1.5 at 15 
hospital discharge compared to the control group (8%) (Chi-Sq=4.39; p=0.04) (Figure 1). 16 
Similarly, there were twice as many infected patients (21%) with a mean INR > 1.5 17 
compared to the control group (11%) (Chi-Sq=3.97; p=0.05) (Figure 1). An INR >1.5 at 18 
day of discharge was more prevalent in the group with wound complications (22%) 19 
compared to patients with uncomplicated postoperative course with regard to wound 20 
healing (8%) (p=0.005). 21 
 There were 13 patients in the periprosthetic infection cohort who had received 22 
injectable anticoagulant in addition to or in lieu of oral anticoagulation in the 23 
 9 
postoperative period that included subcutaneous low-molecular weight heparin (1 case), 1 
and intravenous heparin (12 cases). Heparin was administered as prophylaxis for cardiac 2 
conditions (arrhythmia and prosthetic heart valves). No patient in this cohort developed 3 
pulmonary embolus. Out of the 13 cases that were heparinized, nine patients developed 4 
postoperative wound complications including hematoma (3), persistent wound drainage 5 
(5), and delayed wound healing (1).    6 
Multivariate Analysis 7 
A multiple logistic regression analysis was performed after adjusting for the 8 
various variables. Concomitant comorbidities as measured by ASA (OR=2.07; 95% CI 9 
1.08-.97; p=0.03), postoperative transfusions (OR=1.63; 95% CI 1.14-2.33; p=0.007), 10 
postoperative wound complications including development of hematoma (OR=27.02; 11 
95% CI 11.04-91.59; p=0.0002) and wound drainage (OR=32.20; 95% CI 8.7-119.17; 12 
p<0.0001) were significant risk factors for periprosthetic infection. 13 
 14 
Discussion 15 
Total joint arthroplasty is a successful surgical procedure that continues to confer 16 
functional improvement and alleviation of pain for majority of patients with disabling 17 
arthritis16-19. The outcome of this otherwise successful operation is occasionally 18 
compromised by complications such as periprosthetic infection20-22.  19 
Although implementation of strategies such as clean air operating room, 20 
administration of perioperative antibiotics, and body exhaust systems have all contributed 21 
to prevention of this dreaded complication, periprosthetic infection still continues to 22 
occur after total joint arthroplasty4,5,7. A recent study from the Mayo Clinic found that 23 
 10 
periprosthetic infection has become one of the major causes of failure of total knee 1 
arthroplasty23. The findings of the latter study are truly concerning and raise the question 2 
as to why the incidence of periprosthetic infection may be on the rise. The other pertinent 3 
and inter-related issue is the identification of factors that predispose the patients to 4 
periprosthetic infection.  5 
There is a multitude of reasons that may explain the development of infection 6 
following joint arthroplasty in general and the increase in the incidence of this 7 
complication in particular. First, it may relate to the fact that joint arthroplasty is 8 
currently performed in a wide spectrum of patients including immunocompromised 9 
patients with concomitant comorbidities such as diabetes, malignancy, and steroid use, 10 
which have all been identified as important predisposing factors for periprosthetic 11 
infection8. Second, improvements in prosthetic design and surgical techniques may have 12 
reduced the incidence of mechanical complications, bringing infection to the forefront of 13 
major complications. There may be other explanations also10. Based on our anecdotal 14 
observation, we believed that patients receiving ‘excessive’ anticoagulation such as 15 
intravenous heparin or high dose oral anticoagulant agents during the postoperative 16 
period were at high risk of developing wound related problems that could have in turn 17 
resulted in subsequent periprosthetic infection. This study confirmed the latter and 18 
revealed some important findings.  19 
The incidence of periprosthetic infection was found to be significantly higher in the 20 
group of patients who had a protracted postoperative course related to wound problems. 21 
The latter is intuitive and has in fact been previously reported8. The study, however, did 22 
reveal that there was a direct correlation between ‘excessive’ anticoagulation and 23 
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development of wound related problems that lead to development of subsequent 1 
periprosthetic infection. Excessive anticoagulation was either as a result of administration 2 
of intravenous agents such as heparin to prevent important and potentially life threatening 3 
complications or it resulted from administration of oral agents (warfarin in this case) at a 4 
level that was higher than clinically intended. 5 
The finding that wound complications and subsequent deep infection are associated 6 
with ‘excessive’ anticoagulation is important and at the same time worrisome. Recent 7 
recommendations of American College of Chest Physicians (ACCP) explicitly state that 8 
only agents with proven efficacy should be utilized as prophylaxis against 9 
thromboembolic disease following total joint arthroplasty24. The criteria set forth by the 10 
ACCP, do not recognize low dose warfarin as an effective agent and recommend a higher 11 
level of INR (2 to 2.5). The recommendation also endorses low molecular weight heparin 12 
as an effective agent. The major concern posed by the orthopedic community with regard 13 
to the recommendations of the ACCP relates to the potential for development of wound 14 
related problems such as hematoma and wound drainage that may ensue after aggressive 15 
anticoagulation regimen. The current study confirms that such problems do occur even 16 
after administration of low dose warfarin. Hence, wound related problems and 17 
subsequent infection is likely to be more prevalent after higher doses of anticoagulants or 18 
injectable agents, as the incidence of bleeding, persistent wound drainage, and hematoma 19 
formation has been shown to be higher with injectable agents compared to oral 20 
anticoagulants25,26.  A previous study has also demonstrated that patients receiving 21 
intravenous heparin in the postoperative period were more likely to suffer medical and 22 
orthopedic complication27. The latter study did not however find a correlation between 23 
 12 
anticoagulation and implant related infection. Our study, for the first time to our 1 
knowledge, demonstrates a direct correlation between administration of excessive 2 
anticoagulation and the development of periprosthetic infection. 3 
The findings of this study need to be interpreted with some caveat in mind. This is a 4 
retrospective study with all the innate limitations of such a study design with regard to 5 
uniformity of data collection. Second, it is possible that factors other than excessive 6 
anticoagulation may have lead to the development of periprosthetic infection in this 7 
cohort. This study sought to collect information on all predisposing factors that could 8 
possibly contribute to the development of periprosthetic infection. One of those may have 9 
been the presence of concomitant comorbidities such as diabetes or steroid use. Although 10 
the ASA score was higher in the infected group, there did not seem to be a difference in 11 
the prevalence of diabetes or other ‘predisposing conditions’ between the two groups. 12 
The only exception is that a higher number of patients in the infected group were 13 
receiving oral steroid, as treatment for pulmonary conditions, than the control group. This 14 
difference could plausibly be an important confounding variable. There was also a 15 
significant difference in the ASA score between the two groups. This could however be 16 
explained by the higher incidence of cardiorespiratory conditions among the infected 17 
cohort which in turn lead to more of these patients requiring intravenous anticoagulation. 18 
More patients in the infected cohort required allogenic transfusion in the postoperative 19 
period. Although allogenic transfusion by the virtue of immunonodulation28 can 20 
potentially predispose patients to a higher incidence of infection, this correlation has not 21 
been proven. Instead we believe the higher need for transfusion in the infected cohort is 22 
 13 
the reflection of the problem with bleeding, hematoma formation, and persistent wound 1 
discharge which in turn lead to the need for reoperation and further blood loss. 2 
Despite all the aforementioned limitations, this study serves to highlight an important, 3 
and in our opinion a critical, fact. There needs to be an acceptable balance between 4 
efforts to prevent thromboembolism and the potential for causing serious harm to patients 5 
undergoing total joint arthroplasty. With the continuing improvements in surgical and 6 
anesthesia techniques allowing earlier rehabilitation and faster recovery leading to a 7 
reduced potential for development of thromboembolism, the benefits of aggressive 8 
prophylactic anticoagulation should be weighed against the rising problem of 9 
periprosthetic infection.      10 
 14 
Legends: 1 
Figure 1: The mean International Normalized Ratio (INR) for patients which developed 2 
periprosthetic infection (experimental group) compared to those who did not develop 3 
infection (control group). 4 
Table 1: Details of Various Parameters in the Cohort 5 
Abbreviations: BMI = Body Mass Index; ASA = American Society of Anesthesiologists; 6 
NNIS = National Nosocomial Infection Surveillance; PE= Pulmonary Embolus; DVT= 7 
Deep Vein Thrombosis; UTI= Urinary Tract Infection 8 
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Table1 11 
Variables Cases N=78 Controls N=156 p-value 
Socio-Demographics 
 
       Age in Years(Mean ± SD) 66 ± 10 66 ± 10 0.91 
       BMI Kg/m2 (Mean ± SD) 32 ± 9 32 ± 7 0.76 
       Alcohol Abuse  1 (1%)  0%  0.16 
       Heavy Smoker   6 (8%) 15 (10%)  0.63 
Comorbidities 
 
      ASA score (Mean ± SD) 2.6 ± 0.57 2.4 ± 0.56 0.01 
      Diabetes mellitus 14 (18%) 22 (14%) 0.56 
      ≥3 co-morbidities 33 (42%) 56 (36%) 0.39 
      Steroid Therapy 8 (10%) 5 (3%) 0.03 
      Insulin use 2 (3%) 3 (2%) 0.75 
      NNIS ≥1 50 (64%) 73 (47%) 0.01 
Surgical Data 
 
     Blood loss (Mean ± SD) 354 ± 602 270 ± 341 0.17 
    Operative time (Mean ± SD) 114 ± 49 114 ± 91 0.97 
    Total Transfusion (Mean ± SD) 0.78 ± 1.15 0.39 ± 0.79 0.002 
    Allogenic Transfusion 10 (13%) 3 (2%) 0.0006 
    Autologous Transfusion 47 (60%) 111 (71%) 0.09 
Postoperative Complications 
 
    Wound Hematoma 11 (14%) 2 (1%) 0.0001 
    Wound Drainage 24 (31%) 4 (3%) 0.0001 
    Other complications(PE,DVT,UTI) 18 (23%) 18 (12%) 0.02 
